Patel Naimish 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Patel Naimish（CIK 2021679）在 1 家公司共报告 7 笔 SEC Form 4 内部人交易（最近一笔 2026-06-01）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-06-01 | CRISPR Therapeutics AG (CRSP) | Chief Medical Officer | 买入 | 10,000 | $0 |
| 2026-06-01 | CRISPR Therapeutics AG (CRSP) | Chief Medical Officer | 卖出 | 3,786 | $210,577 |
| 2026-03-17 | CRISPR Therapeutics AG (CRSP) | Chief Medical Officer | 买入 | 8,125 | $0 |
| 2026-03-17 | CRISPR Therapeutics AG (CRSP) | Chief Medical Officer | 卖出 | 3,150 | $152,019 |
| 2026-01-27 | CRISPR Therapeutics AG (CRSP) | Chief Medical Officer | 买入 | 1,508 | $49,704 |
| 2025-05-30 | CRISPR Therapeutics AG (CRSP) | Chief Medical Officer | 买入 | 10,000 | $0 |
| 2025-05-30 | CRISPR Therapeutics AG (CRSP) | Chief Medical Officer | 卖出 | 3,932 | $141,316 |
来源：SEC Form 4 申报文件 · 截至 2026-06-01